• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 REAL-FR 队列的 4 年随访期间神经精神症状的过程。

Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.

机构信息

C.H.U Nice, France.

出版信息

J Nutr Health Aging. 2012 Feb;16(2):134-7. doi: 10.1007/s12603-011-0147-9.

DOI:10.1007/s12603-011-0147-9
PMID:22323347
Abstract

INTRODUCTION

The multicenter PHRC REAL-FR cohort study was designed to follow community-dwelling patients with a diagnosis of Alzheimer's Disease. The present study describes the evolution of neuropsychiatric symptoms (NPS) over 4 years.

METHOD

686 patients were recruited at baseline from 16 French clinical centers. 151 patients were followed over the 4-year interval with 5 Neuropsychiatric evaluations. Neuropsychiatric symptoms were assessed using the Neuropsychiatric inventory (NPI). NPS symptoms were divided into 4 subgroups according to the European Alzheimer Disease Consortium NPI analysis; psychotic subgroup (hallucinations, delusions), hyperactivity subgroup (agitation, aggression, euphoria, disinhibition, irritability, aberrant motor behavior), apathy subgroup (apathy, eating) and affective subgroup (depression, anxiety). Secondly we studied the evolution of the population divided in 4 groups: Apathy only, Hyperactivity only, both Apathy and Hyperactivity, no Apathy no Hyperactivity.

RESULTS

At baseline, 100 patients (66%) presented with one or more clinically significant NPI symptoms. This figure increased to 88% at the end of 4-year follow-up (Linear by linear chi square, p<0, 0012). Five NPI symptoms showed significant increases in prevalence: agitation (17,9 to 29,1%), apathy (43,0 to 62,9%) , disinhibition (2,6 to 14,6%), hallucination (2 to 4,6%) and aberrant motor behavior (13,9 to 29,1%). Prevalence of hyperactivity and apathy subgroups increased significantly during the follow-up while the prevalence of affective and psychotic subgroups did not. The number of patients with both apathy and hyperactivity increased (27% to 44%) during the follow-up period whereas the number of patients without these symptoms decreased (p = .009).

CONCLUSION

The present study shows that 2 types of symptoms increased primarily over time: Apathy and Hyperactivity. The coexistence of such opposite symptoms over time according to our result should be taken into consideration by clinicians treating those patients.

摘要

简介

多中心 PHRC REAL-FR 队列研究旨在随访社区居住的阿尔茨海默病患者。本研究描述了 4 年内神经精神症状(NPS)的演变。

方法

686 例患者于基线时从 16 个法国临床中心招募。151 例患者在 4 年随访期间进行了 5 次神经精神病学评估。使用神经精神病学检查量表(NPI)评估神经精神症状。根据欧洲阿尔茨海默病联盟 NPI 分析,将 NPS 症状分为 4 个亚组:精神病亚组(幻觉、妄想)、多动亚组(激越、攻击、欣快、失抑制、易怒、异常运动行为)、淡漠亚组(淡漠、进食)和情感亚组(抑郁、焦虑)。其次,我们研究了分为 4 组的人群的演变:仅淡漠、仅多动、淡漠和多动、无淡漠无多动。

结果

基线时,100 例(66%)患者出现 1 种或多种临床显著 NPI 症状。这一数字在 4 年随访结束时增加到 88%(线性线性卡方,p<0.0012)。5 种 NPI 症状的患病率显著增加:激越(17.9 至 29.1%)、淡漠(43.0 至 62.9%)、失抑制(2.6 至 14.6%)、幻觉(2 至 4.6%)和异常运动行为(13.9 至 29.1%)。随访期间,多动和淡漠亚组的患病率显著增加,而情感和精神病亚组的患病率没有增加。同时患有淡漠和多动的患者人数增加(27%至 44%),而无症状患者人数减少(p =.009)。

结论

本研究表明,2 种症状主要随时间而增加:淡漠和多动。根据我们的结果,随着时间的推移,这些相反症状的共存应该被治疗这些患者的临床医生考虑。

相似文献

1
Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.在 REAL-FR 队列的 4 年随访期间神经精神症状的过程。
J Nutr Health Aging. 2012 Feb;16(2):134-7. doi: 10.1007/s12603-011-0147-9.
2
Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.阿尔茨海默病患者中需要抗精神病药物治疗的神经精神症状分类:CATIE-AD研究分析
J Alzheimers Dis. 2016;50(3):839-45. doi: 10.3233/JAD-150869.
3
The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period.痴呆症疗养院患者神经精神症状在53个月随访期内的病程。
Int Psychogeriatr. 2014 Jan;26(1):81-91. doi: 10.1017/S1041610213001609. Epub 2013 Sep 23.
4
Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.神经精神症状与轻度认知障碍患者向阿尔茨海默病进展的风险。
J Alzheimers Dis. 2019;70(1):25-34. doi: 10.3233/JAD-190025.
5
Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: symptom clusters.阿尔茨海默病患者神经精神症状的分组和轨迹,第一部分:症状群。
J Alzheimers Dis. 2010;22(4):1157-67. doi: 10.3233/JAD-2010-101212.
6
An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.轻度认知障碍中神经精神症状亚组的探索及其向痴呆或死亡转化的风险。
Am J Geriatr Psychiatry. 2022 Aug;30(8):925-934. doi: 10.1016/j.jagp.2021.12.016. Epub 2022 Jan 3.
7
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.行为亚综合征对阿尔茨海默病认知衰退的影响:来自 ICTUS 研究的数据。
J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1007/s00415-013-6893-3. Epub 2013 Mar 17.
8
Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period.2 年内养老院痴呆患者神经精神症状的发展过程。
Am J Geriatr Psychiatry. 2010 Dec;18(12):1054-65. doi: 10.1097/jgp.0b013e3181f60fa1.
9
Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.神经精神症状与载脂蛋白E:与阿尔茨海默病最终发展的关联。
Arch Gerontol Geriatr. 2016 Jul-Aug;65:231-8. doi: 10.1016/j.archger.2016.04.006. Epub 2016 Apr 14.
10
Grouping and trajectories of neuropsychiatric symptoms in patients with Alzheimer's disease. Part II: two-year patient trajectories.阿尔茨海默病患者神经精神症状的分组和轨迹。第二部分:两年患者轨迹。
J Alzheimers Dis. 2010;22(4):1169-80. doi: 10.3233/JAD-2010-101215.

引用本文的文献

1
Burden in caregivers of primary care patients with dementia: influence of neuropsychiatric symptoms according to disease stage (NeDEM project).痴呆初级保健患者照护者的负担:根据疾病阶段的神经精神症状的影响(NeDEM 项目)。
BMC Geriatr. 2023 Aug 29;23(1):525. doi: 10.1186/s12877-023-04234-0.
2
Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.在初级保健随访中不同痴呆阶段患者的神经精神症状和亚综合征(NeDEM 项目):一项横断面研究。
BMC Geriatr. 2022 Jan 22;22(1):71. doi: 10.1186/s12877-022-02762-9.
3
The Online Life Story Book: A randomized controlled trial on the effects of a digital reminiscence intervention for people with (very) mild dementia and their informal caregivers.

本文引用的文献

1
Behavioral effects of current Alzheimer's disease treatments: a descriptive review.当前阿尔茨海默病治疗方法的行为学效应:描述性综述。
Alzheimers Dement. 2008 Jan;4(1):49-60. doi: 10.1016/j.jalz.2007.10.011.
2
[Clinical and neurophysiological aspects of depression and apathy].
Encephale. 2007 Nov;33(Pt 3):853-5. doi: 10.1016/s0013-7006(07)92907-3.
3
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.痴呆中的神经精神综合征。欧洲阿尔茨海默病联盟的研究结果:第一部分。
《在线生活故事书》:一项关于数字回忆干预对(非常)轻度痴呆症患者及其非正式照护者影响的随机对照试验。
PLoS One. 2021 Sep 15;16(9):e0256251. doi: 10.1371/journal.pone.0256251. eCollection 2021.
4
Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits.阿尔茨海默病所致轻度认知障碍和痴呆中的神经精神症状:与疾病阶段和认知缺陷的关系。
Front Psychiatry. 2021 Aug 17;12:707580. doi: 10.3389/fpsyt.2021.707580. eCollection 2021.
5
Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management.阿尔茨海默病中的抑郁:关于病因、危险因素及临床管理的德尔菲共识
Front Psychiatry. 2021 Feb 26;12:638651. doi: 10.3389/fpsyt.2021.638651. eCollection 2021.
6
Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia.神经精神症状随时间的变化轨迹在健康志愿者中的变化及对 MCI 和痴呆的影响。
Int J Geriatr Psychiatry. 2019 Dec;34(12):1865-1873. doi: 10.1002/gps.5203. Epub 2019 Sep 2.
7
Malnutrition is Associated with Behavioral and Psychiatric Symptoms of Dementia in Older Women with Mild Cognitive Impairment and Early-Stage Alzheimer's Disease.营养不良与轻度认知障碍和早期阿尔茨海默病老年女性痴呆症的行为和精神症状有关。
Nutrients. 2019 Aug 20;11(8):1951. doi: 10.3390/nu11081951.
8
Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia.目前用于治疗痴呆相关行为和心理症状的药物。
Drugs Aging. 2019 Jul;36(7):589-605. doi: 10.1007/s40266-019-00668-7.
9
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia.利用电子健康记录估计阿尔茨海默病/痴呆患者的激越发生率。
Int J Geriatr Psychiatry. 2019 Mar;34(3):420-431. doi: 10.1002/gps.5030. Epub 2018 Dec 27.
10
Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer's Disease.阿尔茨海默病患者神经精神症状的诊断与管理。
Curr Psychiatry Rep. 2018 Oct 27;20(12):117. doi: 10.1007/s11920-018-0978-8.
Dement Geriatr Cogn Disord. 2007;24(6):457-63. doi: 10.1159/000110738. Epub 2007 Nov 7.
4
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study.痴呆症患者神经精神症状的时点患病率和5年期间患病率:卡什县研究
Int J Geriatr Psychiatry. 2008 Feb;23(2):170-7. doi: 10.1002/gps.1858.
5
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.美金刚对接受多奈哌齐治疗的阿尔茨海默病患者的行为影响。
Neurology. 2006 Jul 11;67(1):57-63. doi: 10.1212/01.wnl.0000223333.42368.f1.
6
Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium.痴呆症行为和心理症状的分组:临床与生物学方面。欧洲阿尔茨海默病联盟共识文件
Eur Psychiatry. 2005 Nov;20(7):490-6. doi: 10.1016/j.eurpsy.2004.09.031. Epub 2005 Jan 27.
7
Behavioral and neuropsychiatric outcomes in Alzheimer's disease.阿尔茨海默病的行为和神经精神学转归
CNS Spectr. 2005 Nov;10(11 Suppl 18):22-5. doi: 10.1017/s1092852900014206.
8
A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease.对435例阿尔茨海默病患者神经精神症状的横断面研究。
Am J Geriatr Psychiatry. 2005 Jun;13(6):460-8. doi: 10.1176/appi.ajgp.13.6.460.
9
The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables.痴呆症中神经精神症状的病程。第二部分:行为亚综合征之间的关系及临床变量的影响。
Int J Geriatr Psychiatry. 2005 Jun;20(6):531-6. doi: 10.1002/gps.1317.
10
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.加兰他敏可减轻阿尔茨海默病患者的行为障碍及照料者的痛苦
Am J Psychiatry. 2004 Mar;161(3):532-8. doi: 10.1176/appi.ajp.161.3.532.